Intarcia Logo  
CompanyPeopleProductsCareersMediacontact  
Abstract Image  
 

Product Pipeline >

Type 2 Diabetes

Hepatitis C Infection

Obesity

 

 

 

 


Intarcia Proprietary Product Pipeline

  DUROS Delivery Feasibility Testing Preclinical Phase 1 Phase 2 Phase 3
Type 2 Diabetes          
ITCA 650 >
 
 
 
 
 
DUROS Delivery of Exenatide        
Hepatitis C Infection          
ITCA 638 >
 
 
 
 
 
DUROS Delivery of Type-1 Interferon        
Obesity          
ITCA 880 >
 
 
 
 
 
DUROS Delivery of Weight Regulating Endocrine Peptide        
ITCA 884 >
 
 
 
 
 
DUROS Delivery of Weight Regulating Endocrine Peptide        

 

DUROS Feasability Testing

DUROS Delivery Feasibility Testing involves development of proprietary formulations and evaluation of drug candidates in those formulations to measure purity, stability and bioactivity of the drug candidate under conditions simulating intended clinical use such as exposure to human body temperature for extended periods of time.

 

 

   
 
     
   
COMPANY | PEOPLE | PRODUCTS | TECHNOLOGY | MEDIA | CONTACT | HOME
© Intarcia Therapeutics, Inc. | Privacy Policy & Terms of Use